StockData
Adlai Nortye Group Ltd. logo

Adlai Nortye Group Ltd. (ANL) stock

ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026Score 0/30
$8.55−0.51 (-5.63%)

Close on Nov 20, 2026Market cap $342.00MP/E –Yield –

Adlai Nortye shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 96M, up 0.2% from the year before. The highest annual figure on record is 96M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202596M+0.2%
FY2024Dec 31, 202496M+121.0%
FY2023Dec 31, 202343M+70.4%
FY2022Dec 31, 202225M0.0%
FY2021Dec 31, 202125M–

More Adlai Nortye figures

See a number that looks wrong?